----------
> From: Domenic Spinale <[email protected]>
> To: Rife-List <[email protected]>
> Subject: Re: CS>Off topic:  biopsies
> Date: Saturday, October 10, 1998 11:26 AM
> 
> At 02:16 PM 10/9/98 -0700, Vincent Gammill wrote:
> 
> [snip]
> > Depending on what type of cancer you are looking for, tumor markers
(blood tests) can be very helpful.  AMAS and AMTL are good if you don't
know.  One of the simplest and best would be a delayed type
hypersensitivity reaction (skin test) to GalGalNAc.  It can routinely tell
you if you will be diagnosed with cancer during the next six years or so. I
don't think the insurance companies got wind of it yet!


> What is GalGalNAc and can you provide a URL for more information?
> 
> Domenic

     Its an adhesion glycopeptide that can be isolated from carcinomas and
various other tissues.  Under normal circumstances it's autoimmune
properties are hidden by sialic acid.  It can be used as a component of
what is almost certainly the best cancer vaccine.  The 5-year survival rate
for stage lll and stage lV breast cancers is 100%.  Other carcinomas fair
about as well.  It does require an intradermal injection every 2-3 months
for life.   I'm extracting it from the stroma of type O RBCs.  It is a
tedious process beyond belief.  I do hope to patent part of the procedure. 
I have my doubts though that the FDA will approve a pancarcinoma immunogen.
 They'll end up approving pricey monoclonal antibodies for this marker as
an adjuvant for chemo.  In the cancer industry there is a lot of fear of
this vaccine--and with good cause.
     I'm not sure that this list is the right forum for these discussions. 
Somebody give me some feedback. 
     
Vincent Gammill


--
The silver-list is a moderated forum for discussion of colloidal silver.

To join or quit silver-list or silver-digest send an e-mail message to: 
[email protected]  -or-  [email protected]
with the word subscribe or unsubscribe in the subject: line.

To post, address your message to: [email protected]

List maintainer: Mike Devour <[email protected]>